386 related articles for article (PubMed ID: 32132117)
21. Aberrant methylation of the PTCH1 gene promoter region in aberrant crypt foci.
Peng L; Hu J; Li S; Wang Z; Xia B; Jiang B; Li B; Zhang Y; Wang J; Wang X
Int J Cancer; 2013 Jan; 132(2):E18-25. PubMed ID: 22945423
[TBL] [Abstract][Full Text] [Related]
22. Detection and Characterization of Flat Aberrant Crypt Foci (Flat ACF) in the Novel A/J Min/+ Mouse.
Sødring M; Gunnes G; Paulsen JE
Anticancer Res; 2016 Jun; 36(6):2745-50. PubMed ID: 27272784
[TBL] [Abstract][Full Text] [Related]
23. Comment re: "Sporadic aberrant crypt foci are not a surrogate endpoint for colorectal adenoma prevention" and "Aberrant crypt foci in the adenoma prevention with celecoxib trial".
Stevens RG; Pretlow TP; Hurlstone DP; Giardina C; Rosenberg DW
Cancer Prev Res (Phila); 2008 Aug; 1(3):215-6; author reply 216. PubMed ID: 19138959
[No Abstract] [Full Text] [Related]
24. Suppressive effect of RAS inhibitor manumycin A on aberrant crypt foci formation in the azoxymethane-induced rat colorectal carcinogenesis model.
Tsuda M; Okamoto K; Muguruma N; Sannomiya K; Nakagawa T; Miyamoto H; Kitamura S; Goji T; Kimura T; Okahisa T; Izumi K; Takayama T
J Gastroenterol Hepatol; 2013 Oct; 28(10):1616-23. PubMed ID: 23730936
[TBL] [Abstract][Full Text] [Related]
25. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
[TBL] [Abstract][Full Text] [Related]
26. Abberant crypt foci -- importance in colorectal carcinogenesis and expression of p53 and mdm2: a changing concept.
Das P; Jain D; Vaiphei K; Wig JD
Dig Dis Sci; 2008 Aug; 53(8):2183-8. PubMed ID: 18080767
[TBL] [Abstract][Full Text] [Related]
27. Aberrant crypt foci as microscopic precursors of colorectal cancer.
Cheng L; Lai MD
World J Gastroenterol; 2003 Dec; 9(12):2642-9. PubMed ID: 14669304
[TBL] [Abstract][Full Text] [Related]
28. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
[TBL] [Abstract][Full Text] [Related]
29. Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
Takayama T; Miyanishi K; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Kogawa T; Abe T; Niitsu Y
Clin Gastroenterol Hepatol; 2005 Jul; 3(7 Suppl 1):S42-5. PubMed ID: 16012995
[TBL] [Abstract][Full Text] [Related]
30. Colon epithelial proliferation and carcinogenesis in diet-induced obesity.
Takahashi H; Hosono K; Endo H; Nakajima A
J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():41-7. PubMed ID: 24251703
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa.
Nucci MR; Robinson CR; Longo P; Campbell P; Hamilton SR
Hum Pathol; 1997 Dec; 28(12):1396-407. PubMed ID: 9416697
[TBL] [Abstract][Full Text] [Related]
32. Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
Kowalczyk M; Orłowski M; Siermontowski P; Mucha D; Zinkiewicz K; Kurpiewski W; Zieliński E; Kowalczyk I; Pedrycz A
BMC Cancer; 2018 Feb; 18(1):213. PubMed ID: 29466973
[TBL] [Abstract][Full Text] [Related]
33. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
34. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis.
Hurlstone DP; Cross SS
J Gastroenterol Hepatol; 2005 Feb; 20(2):173-81. PubMed ID: 15683417
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
[TBL] [Abstract][Full Text] [Related]
36. Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats.
Xiao H; Hao X; Simi B; Ju J; Jiang H; Reddy BS; Yang CS
Carcinogenesis; 2008 Jan; 29(1):113-9. PubMed ID: 17893236
[TBL] [Abstract][Full Text] [Related]
37. CpG island methylation in aberrant crypt foci of the colorectum.
Chan AO; Broaddus RR; Houlihan PS; Issa JP; Hamilton SR; Rashid A
Am J Pathol; 2002 May; 160(5):1823-30. PubMed ID: 12000733
[TBL] [Abstract][Full Text] [Related]
38. Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
Quintanilla I; López-Cerón M; Jimeno M; Cuatrecasas M; Zabalza M; Moreira L; Alonso V; Rodríguez de Miguel C; Muñoz J; Castellvi-Bel S; Llach J; Castells A; Balaguer F; Camps J; Pellisé M
Clin Transl Gastroenterol; 2019 Jun; 10(6):e00047. PubMed ID: 31136360
[TBL] [Abstract][Full Text] [Related]
39. Aberrant crypt foci in the adenoma prevention with celecoxib trial.
Cho NL; Redston M; Zauber AG; Carothers AM; Hornick J; Wilton A; Sontag S; Nishioka N; Giardiello FM; Saltzman JR; Gostout C; Eagle CJ; Hawk ET; Bertagnolli MM
Cancer Prev Res (Phila); 2008 Jun; 1(1):21-31. PubMed ID: 19138933
[TBL] [Abstract][Full Text] [Related]
40. Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression.
Drew DA; Mo A; Grady JJ; Stevens RG; Levine JB; Brenner BM; Anderson JC; Forouhar F; O'Brien MJ; Devers TJ; Rosenberg DW
Mol Cancer Res; 2018 Mar; 16(3):486-495. PubMed ID: 29222172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
